Vimarsana
Biggest News Aggregation in the World

Sunovion Pharms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sunovion Pharms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sunovion Pharms Today - Breaking & Trending Today

Federal Circuit Rules on when the Patent Trial and Appeal Board is Engaging in Erroneous Claim Construction | Sheppard Mullin Richter & Hampton LLP - Vimarsana News

Federal Circuit Rules on when the Patent Trial and Appeal Board is Engaging in Erroneous Claim Construction | Sheppard Mullin Richter & Hampton LLP

EcoFactor, Inc. is the holder of U.S. Patent No. 8,498,753, titled “System, Method and Apparatus for Just-In-Time Conditioning Using a Thermostat,” which focuses on optimizing climate...

Court's ANDA Infringement Under Hatch-Waxman Determination - Vimarsana News

Court's ANDA Infringement Under Hatch-Waxman Determination

The US District Court for District of Delaware granted the plaintiff’s motion to exclude defendant’s expert testimony for being based on an erroneous legal theory in a suit alleging defendants’ generic ANDA product would infringe Exela’s patents under the Hatch-Waxman Act.

Court's ANDA Infringement Under Hatch-Waxman Determination - Vimarsana News

Court's ANDA Infringement Under Hatch-Waxman Determination

The US District Court for District of Delaware granted the plaintiff’s motion to exclude defendant’s expert testimony for being based on an erroneous legal theory in a suit alleging defendants’ generic ANDA product would infringe Exela’s patents under the Hatch-Waxman Act.

D. Del. Says ANDA Specification Trumps All Else in Infringement Analysis | Mintz - Intellectual Property Viewpoints - Vimarsana News

D. Del. Says ANDA Specification Trumps All Else in Infringement Analysis | Mintz - Intellectual Property Viewpoints

On February 8, 2022, U.S. District Court Judge Maryellen Noreika of the United States District Court for the District of Delaware granted the plaintiff’s motion to exclude defendant’s...

"About" Patent Claim Construction: Par v. Hospira | Harris Beach PLLC - Vimarsana News

"About" Patent Claim Construction: Par v. Hospira | Harris Beach PLLC

To embed, copy and paste the code into your website or blog: The use of the word “about” in a patent claim as part of a numeric range might permit the patent holder to preclude competitor formulations falling outside the approximate range, as illustrated in a fairly recent decision Par Pharm., Inc. v. Hospira, Inc., 835 F. App'x 578 (Fed. Cir. 2020). Par sued Hospira for patent infringement after Hospira filed an ANDA seeking to market a generic version of Par’s Adrenalin ® epinephrine injection. At issue was the scope of the patent claim listing the approximate amounts of tonicity, ...